Iranian Journal of Radiology

Published by: Kowsar

PI-RADS v2 in Prostate Cancer and Correlation with T Staging, PSA Levels and ADC Values

Kunwarpal Singh 1 , * , Kamlesh Gupta 1 , C. L. Thukral 1 , Priya Goyal 1 , Vijinder Arora 2 and Inderbir Singh 2
Authors Information
1 Department of Radiodiagnosis and Imaging, Sri Guru Ram Das Institute of Medical Sciences and Research, Vallah, Sri Amritsar, Baba Farid University of Health Sciences, Faridkot, India
2 Department of MRI, NIJJER SCAN and Diagnostic Centre, Amritsar, India
Article information
  • Iranian Journal of Radiology: January 2018, 15 (1); e14038
  • Published Online: December 23, 2017
  • Article Type: Research Article
  • Received: April 10, 2017
  • Revised: October 21, 2017
  • Accepted: November 4, 2017
  • DOI: 10.5812/iranjradiol.14038

To Cite: Singh K, Gupta K, Thukral C L, Goyal P, Arora V, et al. PI-RADS v2 in Prostate Cancer and Correlation with T Staging, PSA Levels and ADC Values, Iran J Radiol. 2018 ; 15(1):e14038. doi: 10.5812/iranjradiol.14038.

Copyright © 2017, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Futterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, et al. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol. 2015;68(6):1045-53. doi: 10.1016/j.eururo.2015.01.013. [PubMed: 25656808].
  • 2. Heidenreich A. Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol. 2011;59(4):495-7. doi: 10.1016/j.eururo.2011.01.013. [PubMed: 21256671].
  • 3. Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, et al. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol. 2016;69(1):41-9. doi: 10.1016/j.eururo.2015.08.038. [PubMed: 26361169].
  • 4. Hassanzadeh E, Glazer DI, Dunne RM, Fennessy FM, Harisinghani MG, Tempany CM. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdom Radiol (NY). 2017;42(1):278-89. doi: 10.1007/s00261-016-0871-z. [PubMed: 27522352].
  • 5. Durmus T, Baur A, Hamm B. Multiparametric magnetic resonance imaging in the detection of prostate cancer. Aktuelle Urol. 2014;45(2):119-26. doi: 10.1055/s-0034-1371875. [PubMed: 24700068].
  • 6. Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology. 2011;261(1):46-66. doi: 10.1148/radiol.11091822. [PubMed: 21931141].
  • 7. Villeirs GM, Oosterlinck W, Vanherreweghe E, De Meerleer GO. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer. Eur J Radiol. 2010;73(2):352-6. doi: 10.1016/j.ejrad.2008.10.034. [PubMed: 19084363].
  • 8. Afifi AH, Ramadan AA, Alabbady A, Khalifa MHA. Multi-parametric MRI and PI-RADS (V1) scoring system: New inception in cancer prostate diagnosis to evaluate diagnostic performance of different score combinations. Egypt J Radiol Nuclear Med. 2016;47(3):1083-94. doi: 10.1016/j.ejrnm.2016.04.015.
  • 9. Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA, Hambrock T, Futterer JJ, Witjes JA, et al. Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Invest Radiol. 2013;48(3):152-7. doi: 10.1097/RLI.0b013e31827b711e. [PubMed: 23328910].
  • 10. Hamoen EHJ, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. Eur Urol. 2015;67(6):1112-21. doi: 10.1016/j.eururo.2014.10.033. [PubMed: 25466942].
  • 11. Platzek I, Borkowetz A, Toma M, Brauer T, Meissner C, Dietel K, et al. Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added Value. J Comput Assist Tomogr. 2015;39(5):674-80. doi: 10.1097/RCT.0000000000000261. [PubMed: 25938212].
  • 12. Tan CH, Hobbs BP, Wei W, Kundra V. Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol. 2015;204(4):W439-48. doi: 10.2214/AJR.14.13373. [PubMed: 25794093].
  • 13. Rosenkrantz AB, Oto A, Turkbey B, Westphalen AC. Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look. AJR Am J Roentgenol. 2016;206(6):1179-83. doi: 10.2214/AJR.15.15765. [PubMed: 26913638].
  • 14. Kasel-Seibert M, Lehmann T, Aschenbach R, Guettler FV, Abubrig M, Grimm MO, et al. Assessment of PI-RADS v2 for the Detection of Prostate Cancer. Eur J Radiol. 2016;85(4):726-31. doi: 10.1016/j.ejrad.2016.01.011. [PubMed: 26971415].
  • 15. Tewes S, Mokov N, Hartung D, Schick V, Peters I, et al. Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS)Version 1 and Version 2. PLoS One. 2016;11(9). doi: 10.1371/journal.pone.0162879.
  • 16. Alonzi R, Padhani AR. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol. 2007 9;63(3):335-50. doi: 10.1016/j.ejrad.2007.06.028. [PubMed: 17689907].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments